文献速递瓣膜外科

当代实践中退行性二尖瓣修复术后再次阻断主动脉的临床分析

Second cross-clamping after mitral valve repair for degenerative disease in contemporary practice.
PubMed 文献 · Eur J Cardiothorac Surg · 2018-01-01

本研究纳入2318例因重度退行性二尖瓣反流接受二尖瓣修复的患者,其中94例(4%)行再次阻断主动脉。再次阻断最常见原因为残余反流>1+/4+和收缩期前向运动。再次阻断组院内死亡率为0%,对照组为0.3%(P=0.2),两组术后并发症和住院时间相似。作者认为再次阻断的阈值较低似乎是合理的。

要点

  • 再次阻断主动脉发生率为4%(94/2318),最常见原因为残余二尖瓣反流>1+/4+和收缩期前向运动。
  • 再次阻断组院内死亡率为0%,对照组为0.3%(P=0.2),术后并发症及住院时间两组相似。
  • 再次阻断组12年再手术、复发性反流≥3+和反流≥2+(以死亡为竞争风险)的累积发生率分别为5.7±2.5%、10.3±4.3%和17±5.2%。

核心结论

  • 在二尖瓣修复高容量中心,再次阻断主动脉仍在3-5%的患者中实施;因即刻结果欠佳与二尖瓣重建的晚期结局受损相关,作者认为较低的再次阻断阈值似乎是合理的。
  • 若再次修复时额外阻断时间相对较短,死亡率和并发症不增加,即刻和长期结果非常满意。

研究设计与样本

  • 研究人群包括2318例因重度退行性二尖瓣反流转诊行二尖瓣修复的患者,其中94例(4%)行再次阻断主动脉,2224例为单次阻断对照组。
  • 评估再次阻断的原因、修复修正程序、即刻超声心动图结果和术后病程,并与对照组比较。
  • 94例再次阻断患者中91例(97%完整)有临床和超声心动图随访信息,中位随访时间6年(四分位距3-11)。

主要发现

  • 再次阻断最常见原因为残余二尖瓣反流>1+/4+和收缩期前向运动;残余脱垂41例(43.5%),收缩期前向运动22例(23.5%),未处理裂隙14例(15%),其他机制17例(18%)。
  • 第二次体外循环和主动脉阻断时间分别为36分钟(范围28-50)和23分钟(范围17-34)。
  • 院内死亡率再次阻断组为0%,对照组为0.3%(P=0.2);术后并发症和住院时间两组相似。
  • 出院时残余二尖瓣反流≥2+/4+在再次阻断组为2.1%,对照组为2.7%(P=0.99)。
  • 再次阻断组12年时,再手术、复发性二尖瓣反流≥3+和反流≥2+(以死亡为竞争风险)的累积发生率分别为5.7±2.5%(95%CI 2-12)、10.3±4.3%(95%CI 3.8-20)和17±5.2%(95%CI 8-29)。

关键数值与推荐

  • 再次阻断主动脉的指征包括残余二尖瓣反流>1+/4+和收缩期前向运动。
  • 再次阻断组第二次体外循环时间36分钟(范围28-50),第二次主动脉阻断时间23分钟(范围17-34)。

临床怎么用

  • 作者认为,因即刻结果欠佳与二尖瓣重建的晚期结局受损相关,较低的再次阻断阈值似乎是合理的。
  • 作者认为,若再次修复时额外阻断时间相对较短,死亡率和并发症不增加,即刻和长期结果非常满意。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Scanty data are available on 'second cross-clamping' following mitral valve repair in contemporary practice. The aim of this study was to evaluate the incidence, causes and outcomes of this event in patients referred for mitral repair for severe degenerative mitral regurgitation (MR). METHODS: The study population included 2318 patients with severe degenerative MR referred for mitral repair. A second cross-clamping was performed in 94 (4%) patients. Causes of the second cross-clamping, revising repair procedures, immediate echocardiographic outcomes and postoperative course were assessed and compared with the 'single cross-clamping cases' (2224 patients used as control). Clinical and echocardiographic follow-up information was available for 91 of the 94 second cross-clamping patients (97% complete) (median time 6 years, interquartile range 3-11). RESULTS: The most frequent causes of the second cross-clamping were residual MR >1+/4+ and systolic anterior motion. A residual prolapse was identified in 41 (43.5%) patients, systolic anterior motion in 22 (23.5%), untreated clefts in 14 (15%) and other mechanisms in 17 (18%). Second cardiopulmonary bypass and aortic cross-clamping times were 36 (range 28-50) and 23 (range 17-34) min, respectively. Hospital mortality was 0% in the second cross-clamping and 0.3% in the control group (P = 0.2). Postoperative complications and length of hospital stay were similar. At discharge, residual MR ≥2+/4+ was 2.1% in the second cross-clamping and 2.7% in the control group (P = 0.99). In the second cross-clamping, at 12 years, the cumulative incidence function of reoperation, recurrent MR ≥3+ and MR ≥2+ with death as competing risk were 5.7 ± 2.5% (95% confidence interval 2-12), 10.3 ± 4.3% (95% confidence interval 3.8-20) and 17 ± 5.2% (95% confidence interval 8-29), respectively. CONCLUSIONS: In a large volume centre for mitral repair, a second cross-clamping is still performed in 3-5% of the patients. Because suboptimal immediate results are associated with impaired late outcomes of mitral reconstruction, a low threshold for a second cross-clamping seems to be justified. If the second repair is carried out with a relatively shorter additional cross-clamping time, mortality and morbidity are not increased and immediate and long-term results are very satisfactory.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. De Bonis M, Lapenna E, Giambuzzi I, et al. Second cross-clamping after mitral valve repair for degenerative disease in contemporary practice. Eur J Cardiothorac Surg. 2018. PMID: 29370363. doi:10.1093/ejcts/ezx507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。